Literature DB >> 24059568

CSF Flow in Chiari I and Syringomyelia from the Perspective of Computational Fluid Dynamics.

K-H Støverud1, K-A Mardal, V Haughton, H P Langtangen.   

Abstract

Phase contrast MR in patients with the Chiari I malformation demonstrates abnormal CSF flow in the foramen magnum and upper cervical spinal canal, related to abnormal pressure gradients. The purpose of this study was to analyze the role of CSF pressure in the pathogenesis of syringomyelia, with computational models. The spinal cord was modeled as a cylindrical poro-elastic structure with homogenous and isotropic permeability. The permeability was then made heterogeneous and anisotropic to represent the different properties of the central canal, gray and white matter. Fluid with a defined pressure, varying both in time and space, was prescribed in the SAS. Simulations were performed to quantify deformations and fluid movement within the cord. In the simulations with uniform permeability fluid moved into the cord in regions of higher pressure and out of the cord in regions of lower pressure. With permeability differences simulating gray and white matter the pattern was more complex, but similar. Adding the central spinal canal, fluid moved into the cord as in the previous case. However, preferential flow along the central canal hindered fluid from flowing back into the SAS. Pressure gradients in the SAS produce movement of fluid in the spinal cord. Assuming different relative permeability in gray matter, white matter and the central spinal canal, abnormal CSF gradients lead to accumulation of fluid within and adjacent to the spinal cord central canal.

Entities:  

Year:  2011        PMID: 24059568     DOI: 10.1177/197140091102400106

Source DB:  PubMed          Journal:  Neuroradiol J        ISSN: 1971-4009


  1 in total

1.  Effect of the central canal in the spinal cord on fluid movement within the cord.

Authors:  Ida N Drøsdal; Kent-Andre Mardal; Karen Støverud; Victor Haughton
Journal:  Neuroradiol J       Date:  2013-11-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.